PLRX — Pliant Therapeutics Inc · $77.3M cap

Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.

Latest reported PLRX revenue for 2025-12-31 was $0. Net income was -$149.3M. PLRX currently screens at market cap $77.3M.

Use this PLRX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PLRX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PLRX SEC filings page. Lician reads the product cache first so this HTML stays unique to Pliant Therapeutics Inc even when a live quote feed is slow.

Pliant Therapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full PLRX income, balance, and cash tables.

  • Revenue$0
  • Net Income-$149.3M
  • Total Assets$225.2M
  • Total Debt$0
  • Free Cash Flow-$128.7M

PLRX recent filings